Literature DB >> 18396079

A double-edged sword: erythropoietin eyed in retinopathy of prematurity.

Jing Chen, Lois E H Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18396079     DOI: 10.1016/j.jaapos.2008.02.001

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


× No keyword cloud information.
  8 in total

Review 1.  Advances in understanding and management of retinopathy of prematurity.

Authors:  Mary Elizabeth Hartnett
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

2.  A predictive score for retinopathy of prematurity in very low birth weight preterm infants.

Authors:  G U Eckert; J B Fortes Filho; M Maia; R S Procianoy
Journal:  Eye (Lond)       Date:  2011-12-23       Impact factor: 3.775

Review 3.  The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatment.

Authors:  Lois E Smith; Anna-Lena Hard; Ann Hellström
Journal:  Clin Perinatol       Date:  2013-06       Impact factor: 3.430

4.  A novel model of retinopathy of prematurity in normobaric hyperoxic conditions.

Authors:  Taner Ozgurtas; Sercan Tekin; Fatih Yesildal; Umut Karaca; Fevzi Nuri Aydin; Muhammed Talha Ugurlu; Mehmet Ozler; Hakan Durukan
Journal:  Int J Ophthalmol       Date:  2016-09-18       Impact factor: 1.779

Review 5.  Retinopathy of prematurity: current concepts in molecular pathogenesis.

Authors:  Gena Heidary; Deborah Vanderveen; Lois E Smith
Journal:  Semin Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 1.975

6.  A review of treatment for retinopathy of prematurity.

Authors:  Eric D Hansen; M Elizabeth Hartnett
Journal:  Expert Rev Ophthalmol       Date:  2019-03-29

7.  Possibility of enhanced risk of retinal neovascularization in repeated blood donors: blood donation and retinal alteration.

Authors:  Reza Rastmanesh
Journal:  Int J Gen Med       Date:  2011-09-06

8.  Systemic administration of erythropoietin inhibits retinopathy in RCS rats.

Authors:  Weiyong Shen; Sook H Chung; Mohammad R Irhimeh; Shiying Li; So-Ra Lee; Mark C Gillies
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.